12th Annual FDA Sentinel Public Workshop

The Sentinel Initiative, an active medical product surveillance system, was established in response to the Food and Drug Administration (FDA) Amendments Act of 2007 and has become one of the Agency’s premier evidence generation platforms. The 12th Annual Sentinel Initiative Public Workshop is being convened on April 20-21, 2020 by the Robert J. Margolis, MD, Center for Health Policy under a cooperative agreement with the FDA. The two-day workshop will be held at the Washington Plaza Hotel in Washington, DC and provides an opportunity to discuss recent achievements and engage with the broader community of patients, consumers, and scientific stakeholders.

Spotlight


OTHER PAST CONFERENCES

8th Microbiome Movement - Drug Development Summit Europe

January 30-February 1, 2024 | Spain

With new clinical data and more ground-breaking advancements in the technology underpinning microbiome research, Europe’s leading microbiome organisations are paving the way for drug development! Join us at the 8th Microbiome Movement- Drug Development Summit Europe where we will cover the most exciting progress in the microbiome world, from expanded analytics and larger-scale manufacturing to the most pressing challenges from translation to regulations. In January, 150+ microbiome innovators will be united in Barcelona for the flagship meeting for European microbiome-based therapeutic developers. We are bringing together microbiome trailblazers across industry, academia and investors to share their insights across autoimmune disorders, oncology, lung disease, hepatic disease, women’s health and more! Now with new interactive sessions such as a reverse pitch opportunity, technology showcase, poster session and guided networking. This unmissable event will provide you with the opportunity to transform your drug development pipelines and meet like-minded individuals to help you along the way.

International Conference on Antibiotics and Pharmacy Practice (ICAPP-24)

March 7-8, 2024 | Singapore

A premier global platform for the International Conference on Antibiotics and Pharmacy Practice ICAPP welcomes you to its official web page. We’re very happy and proud of our pioneering and innovative renaissance, which has enabled us to introduce and research many revolutionary concepts and philosophies. To be held on 07th - 08th-Mar-2024 at Singapore

BioPharma & Life Sciences Connected Live

January 25, 2024 | Ireland

Book your place at the Biopharma & Life Sciences Connected conference and exhibition to hear from leading national and international experts in pharmaceutical manufacturing. The biopharma sector in Ireland is experiencing significant challenges around supply chain issues, digital transformation, automation, carbon reduction and regulatory changes.. The central theme of this event is to hear directly from industry leaders and stakeholders who are willing to share challenges and solutions in practice. That means, the spotlight in presentations will be on case studies from pharmaceutical companies - allowing you to benefit from the speakers' experience in their everyday practice. Over 75 leading speakers involved in the development & manufacturing of biopharmaceutical & biotech products & technology will participate in a full day's schedule of keynote talks & panels on the topics shaping the sector. Why Attend Listen to over 75 expert talks and panel debates on the latest industry issues facing the biopharma & life sciences sector. Avail of the excellent networking opportunities with peers throughout the day Network with over 70 exhibitors displaying the latest technology and research Meet with government support agencies and associations Join our Q&A with industry thought leaders

2024 ISPE Aseptic Conference

March 12-13, 2024 | Austria

In the constantly evolving field of pharmaceutical manufacturing, the imperative to embrace new technologies and innovative strategies for process control and efficiency is more pressing than ever before. Recent advancements in aseptic processing, such as advanced isolators, robotics, and increased automation, have transformed the industry whilst simultaneously reducing the risks of contamination for sterile products. However, modern therapies - innovative, targeted treatments that result in small-batch aseptic products - require faster speeds to market and present unique sterilization and handling challenges. This dichotomy presents unique challenges for the industry to address. Moreover, the updated Annex 1 is impacting the manufacturing of sterile products, necessitating updated requirements such as Quality Risk Management, Contamination Control Strategy, and Data Management and Compliance for Computerized Systems. In light of these urgent needs, the 2024 ISPE Aseptic Conference will provide an ideal opportunity for participants to share progress, success stories, best practices, and lessons learned. Get ahead of the game with a focus on novel therapies, emerging technologies, and aseptic processing. We look forward to seeing you in Vienna, Austria!